Watchlist Price Alert

Aileron Therapeutics Inc. (ALRN)

NASDAQ: ALRN · Real-Time Price · USD

2.11

0.18 (9.33%)

At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	119K	169K	121K	163K	155K	218K	95K	232K
Gross Profit	n/a	-119K	-169K	-121K	-163K	-155K	-218K	-95K	-232K
Operating Income	-65.11M	-16.28M	-27.65M	-26.61M	-20.5M	-29.96M	-31.9M	-23.01M	-18.17M
Interest Income	n/a	n/a	n/a	n/a	n/a	587K	355K	404K	46K
Pretax Income	-62.88M	-15.73M	-27.33M	-26.2M	-21.16M	-29.37M	-31.55M	-22.6M	-18.12M
Net Income	-62.88M	-15.73M	-27.01M	-25.76M	-21.82M	-28.78M	-31.55M	-22.6M	-18.12M
Selling & General & Admin	13.86M	11.36M	9.68M	9.6M	9.33M	12.29M	13.45M	8.77M	7.89M
Research & Development	14.25M	3.99M	17.97M	17.01M	11.17M	17.66M	18.45M	14.24M	10.28M
Other Expenses	37M	928K	318K	441K	-800K	n/a	n/a	n/a	-18.17M
Operating Expenses	65.11M	16.28M	27.65M	26.61M	20.5M	29.96M	31.9M	23.01M	18.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	16.28M	27.65M	26.61M	20.5M	29.96M	31.9M	23.01M	18.17M
Income Tax Expense	n/a	n/a	-318K	-441K	661K	-587K	355K	34K	n/a
Shares Outstanding (Basic)	17.94M	4.6M	4.54M	4.44M	1.74M	1.23M	736.91K	372.15K	545.72K
Shares Outstanding (Diluted)	17.94M	4.6M	4.54M	4.44M	1.74M	1.23M	736.91K	372.15K	545.72K
EPS (Basic)	-3.51	-3.42	-5.95	-5.8	-12.52	-23.46	-42.81	-60.74	-33.21
EPS (Diluted)	-3.51	-3.42	-5.95	-5.8	-12.52	-23.46	-42.81	-60.74	-33.21
EBITDA	-65.11M	-15.61M	-27.48M	-26.48M	-20.33M	-29.8M	-31.33M	-23.01M	-17.94M
EBIT	n/a	-15.73M	-27.65M	-26.61M	-20.5M	-29.96M	-31.55M	-22.6M	-18.17M
Depreciation & Amortization	n/a	119K	169K	121K	163K	155K	218K	95K	232K